Li-Wei Lo1, Yenn-Jiang Lin1, Shih-Lin Chang1, Yu-Feng Hu1, Fa-Po Chung1, Shih-Ann Chen2. 1. Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital; Institute of Clinical Medicine, and Cardiovascular Research Institute, National Yang-Ming University, 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan. 2. Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital; Institute of Clinical Medicine, and Cardiovascular Research Institute, National Yang-Ming University, 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan. epsachen@ms41.hinet.net.
Abstract
PURPOSE OF REVIEW: Pulmonary vein (PV) isolation is the cornerstone of atrial fibrillation (AF) ablation. However, the long-term procedural outcome remains suboptimal and there is a frequent need for repeat ablation procedure, especially in patients with non-paroxysmal AF. The review article summarizes the rationales, recent evidences, and strategies of ablation of extra-PV sites and its clinical outcomes. RECENT FINDINGS: It is a consensus that durable PV isolations are a definite therapy in patients with paroxysmal AF. In non-paroxysmal AF, many laboratories still believe that adequate substrate ablation outside PVs is definitely required. Empirical linear ablation is not recommended because of difficulty in achieving complete linear block, unless macro-reentry atrial tachycardia developed during procedure. Most of laboratories applied complex fractionated atrial electrogram (CFAE) ablation after PV isolation in non-paroxysmal AF, but the efficacy is limited in the long-term follow-up studies. A combined approach using CFAE, non-linear similarity, and phase mapping strategy to identify rotors or focal sources for substrate modification increases the ablation outcome, when compared to CFAE ablation alone. Provocative test with mapping of non-PV triggers is also recommended in all patients to improve long-term ablation success. Ablation beyond PV isolation is important, especially in non-paroxysmal AF patients, to modify the diseased atrial substrate and eliminate the non-PV triggers, which in turn improve the ablation outcome.
PURPOSE OF REVIEW: Pulmonary vein (PV) isolation is the cornerstone of atrial fibrillation (AF) ablation. However, the long-term procedural outcome remains suboptimal and there is a frequent need for repeat ablation procedure, especially in patients with non-paroxysmal AF. The review article summarizes the rationales, recent evidences, and strategies of ablation of extra-PV sites and its clinical outcomes. RECENT FINDINGS: It is a consensus that durable PV isolations are a definite therapy in patients with paroxysmal AF. In non-paroxysmal AF, many laboratories still believe that adequate substrate ablation outside PVs is definitely required. Empirical linear ablation is not recommended because of difficulty in achieving complete linear block, unless macro-reentry atrial tachycardia developed during procedure. Most of laboratories applied complex fractionated atrial electrogram (CFAE) ablation after PV isolation in non-paroxysmal AF, but the efficacy is limited in the long-term follow-up studies. A combined approach using CFAE, non-linear similarity, and phase mapping strategy to identify rotors or focal sources for substrate modification increases the ablation outcome, when compared to CFAE ablation alone. Provocative test with mapping of non-PV triggers is also recommended in all patients to improve long-term ablation success. Ablation beyond PV isolation is important, especially in non-paroxysmal AFpatients, to modify the diseased atrial substrate and eliminate the non-PV triggers, which in turn improve the ablation outcome.
Authors: Stephan Willems; Hanno Klemm; Thomas Rostock; Benedikt Brandstrup; Rodolfo Ventura; Daniel Steven; Tim Risius; Boris Lutomsky; Thomas Meinertz Journal: Eur Heart J Date: 2006-06-16 Impact factor: 29.983
Authors: David Lin; David S Frankel; Erica S Zado; Edward Gerstenfeld; Sanjay Dixit; David J Callans; Michael Riley; Mathew Hutchinson; Fermin Garcia; Rupa Bala; Ralph Verdino; Joshua Cooper; Francis E Marchlinski Journal: J Cardiovasc Electrophysiol Date: 2012-04-17
Authors: Anthony G Brooks; Martin K Stiles; Julien Laborderie; Dennis H Lau; Pawel Kuklik; Nicholas J Shipp; Li-Fern Hsu; Prashanthan Sanders Journal: Heart Rhythm Date: 2010-01-22 Impact factor: 6.343
Authors: Zhibing Lu; Benjamin J Scherlag; Jiaxiong Lin; Guodong Niu; Muhammad Ghias; Warren M Jackman; Ralph Lazzara; Hong Jiang; Sunny S Po Journal: J Cardiovasc Electrophysiol Date: 2008-03-26
Authors: Geoffrey Lee; Saurabh Kumar; Andrew Teh; Andrew Madry; Steven Spence; Marco Larobina; John Goldblatt; Robin Brown; Victoria Atkinson; Simon Moten; Joseph B Morton; Prashanthan Sanders; Peter M Kistler; Jonathan M Kalman Journal: Eur Heart J Date: 2013-08-08 Impact factor: 29.983